BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11691805)

  • 1. Therapeutic efficacy of aortic administration of N-acetylcysteine as a chemoprotectant against bone marrow toxicity after intracarotid administration of alkylators, with or without glutathione depletion in a rat model.
    Neuwelt EA; Pagel MA; Hasler BP; Deloughery TG; Muldoon LL
    Cancer Res; 2001 Nov; 61(21):7868-74. PubMed ID: 11691805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rescue from enhanced alkylator-induced cell death with low molecular weight sulfur-containing chemoprotectants.
    Muldoon LL; Walker-Rosenfeld SL; Hale C; Purcell SE; Bennett LC; Neuwelt EA
    J Pharmacol Exp Ther; 2001 Mar; 296(3):797-805. PubMed ID: 11181909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow chemoprotection without compromise of chemotherapy efficacy in a rat brain tumor model.
    Neuwelt EA; Pagel MA; Kraemer DF; Peterson DR; Muldoon LL
    J Pharmacol Exp Ther; 2004 May; 309(2):594-9. PubMed ID: 14752063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of buthionine sulfoximine (NSC 326231) and its effect on melphalan-induced toxicity in mice.
    Smith AC; Liao JT; Page JG; Wientjes MG; Grieshaber CK
    Cancer Res; 1989 Oct; 49(19):5385-91. PubMed ID: 2766304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of glutathione depletion by L-buthionine sulfoximine on the cytotoxicity of cyclophosphamide in single and fractionated doses to EMT6/SF mouse tumors and bone marrow.
    Ono K; Shrieve DC
    J Natl Cancer Inst; 1987 Oct; 79(4):811-5. PubMed ID: 3477662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed administration of sodium thiosulfate in animal models reduces platinum ototoxicity without reduction of antitumor activity.
    Muldoon LL; Pagel MA; Kroll RA; Brummett RE; Doolittle ND; Zuhowski EG; Egorin MJ; Neuwelt EA
    Clin Cancer Res; 2000 Jan; 6(1):309-15. PubMed ID: 10656463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
    Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
    Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection against cisplatin-induced toxicities by N-acetylcysteine and sodium thiosulfate as assessed at the molecular, cellular, and in vivo levels.
    Dickey DT; Wu YJ; Muldoon LL; Neuwelt EA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1052-8. PubMed ID: 15951398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manipulation of energy and redox states in the C6 glioma cells by buthionine sulfoxamine and N-acetylcysteine and the effect on cell survival to cadmium toxicity.
    Yang MS; Yu LC; Pat SW
    Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):56-61. PubMed ID: 17519112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Buthionine (S,R) sulfoximine depletes hepatic glutathione but protects against ethanol-induced liver injury.
    Donohue TM; Curry-McCoy TV; Todero SL; White RL; Kharbanda KK; Nanji AA; Osna NA
    Alcohol Clin Exp Res; 2007 Jun; 31(6):1053-60. PubMed ID: 17428293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione depletion by buthionine sulfoximine induces DNA deletions in mice.
    Reliene R; Schiestl RH
    Carcinogenesis; 2006 Feb; 27(2):240-4. PubMed ID: 16162646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of preconditioning with N-acetylcysteine against reperfusion injury after prolonged cold ischaemia in rats liver in which glutathione had been reduced by buthionine sulphoximine.
    Nagasaki H; Nakano H; Boudjema K; Jaeck D; Alexandre E; Baek Y; Kitamura N; Yamaguchi M; Kumada K
    Eur J Surg; 1998 Feb; 164(2):139-46. PubMed ID: 9537722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glutathione synthesis is not involved in protection by N-acetylcysteine against UVB-induced systemic immunosuppression in mice.
    Steenvoorden DP; Beijersburgen van Henegouwen GM
    Photochem Photobiol; 1998 Jul; 68(1):97-100. PubMed ID: 9679454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
    Chen N; Aleksa K; Woodland C; Rieder M; Koren G
    Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of N-acetyl cysteine, buthionine sulfoximine, diethyldithiocarbamate or 3-amino-1,2,4-triazole on antimycin A-treated Calu-6 lung cells in relation to cell growth, reactive oxygen species and glutathione.
    Han YH; Park WH
    Oncol Rep; 2009 Aug; 22(2):385-91. PubMed ID: 19578781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic cytotoxicity of buthionine sulfoximine (BSO) and intensive melphalan (L-PAM) for neuroblastoma cell lines established at relapse after myeloablative therapy.
    Anderson CP; Reynolds CP
    Bone Marrow Transplant; 2002 Aug; 30(3):135-40. PubMed ID: 12189530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased delivery and acute toxicity of cranial irradiation and chemotherapy given with osmotic blood-brain barrier disruption in a rodent model: the issue of sequence.
    Remsen LG; McCormick CI; Sexton G; Pearse HD; Garcia R; Neuwelt EA
    Clin Cancer Res; 1995 Jul; 1(7):731-9. PubMed ID: 9816039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lead induced oxidative stress and its recovery following co-administration of melatonin or N-acetylcysteine during chelation with succimer in male rats.
    Flora SJ; Pande M; Kannan GM; Mehta A
    Cell Mol Biol (Noisy-le-grand); 2004; 50 Online Pub():OL543-51. PubMed ID: 15555419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of resistance to regional chemotherapy in the extremity melanoma model.
    Grubbs EG; Ueno T; Abdel-Wahab O; Cheng TY; Pruitt SK; Michael Colvin O; Friedman HS; Tyler DS
    Surgery; 2004 Aug; 136(2):210-8. PubMed ID: 15300182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent pharmacodynamic models in cancer chemotherapy: population pharmacodynamic model for glutathione depletion following modulation by buthionine sulfoximine (BSO) in a Phase I trial of melphalan and BSO.
    Gallo JM; Brennan J; Hamilton TC; Halbherr T; Laub PB; Ozols RF; O'Dwyer PJ
    Cancer Res; 1995 Oct; 55(20):4507-11. PubMed ID: 7553617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.